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Abstract. 
 
Smooth muscle myosin in the dephosphory-
lated state does not form ﬁlaments in vitro. However, 
thick ﬁlaments, which are composed of myosin and my-
osin-binding protein(s), persist in smooth muscle cells, 
even if myosin is subjected to the phosphorylation–
dephosphorylation cycle. The characterization of
telokin as a myosin-assembling protein successfully ex-
plained the discrepancy. However, smooth muscle cells 
that are devoid of telokin have been observed. We ex-
pected to ﬁnd another ubiquitous protein with a similar 
role, and attempted to purify it from chicken gizzard. 
The 38k protein bound to both phosphorylated and de-
phosphorylated myosin to a similar extent. The effect of 
the myosin-binding activity was to assemble dephos-
phorylated myosin into ﬁlaments, although it had no ef-
fect on the phosphorylated myosin. The 38k protein 
bound to myosin with both COOH-terminal 20 and 
 
NH
 
2
 
-terminal 28 residues of the 38k protein being es-
sential for myosin binding. The amino acid sequence of 
the 38k protein was not homologous to telokin, but to 
human p32, which was originally found in nuclei as a 
subunit of pre-mRNA splicing factor-2. Western blot-
ting showed that the protein was expressed in various 
smooth muscles. Immunoﬂuorescence microscopy with 
cultured smooth muscle cells revealed colocalization of 
the 38k protein with myosin and with other cytoskeletal 
elements. The absence of nuclear immunostaining was 
discussed in relation to smooth muscle differentiation.
Key words: myosin assembly • myosin binding • myo-
sin ﬁlament • human p32 • smooth muscle
 
Introduction
 
The thick filaments observed in various muscle cells are
composed of myosin filaments that are associated with
myosin-binding proteins. Assembly into filaments is an in-
herent property of myosin (Huxley, 1963). Myosin-binding
 
proteins, such as myosin-binding protein-C (C-protein)
 
1
 
,
myosin-binding protein-H (H-protein), M-protein, titin,
and myomesin are thought to stabilize the filaments (for
review, see Epstein and Fischman, 1991; Furst and Gautel,
1995).
In the case of skeletal muscle myosin, assembly is ob-
served regardless of the phosphorylation state of myosin.
However, smooth muscle myosin does not form filaments
unless its regulatory light chain (RLC) is phosphorylated
(for review, see Stull et al., 1991; Trybus, 1991; Gallagher
et al., 1997). Smooth muscle myosin molecules, if not
phosphorylated, are in a folded structure called the 10S
form, and hardly assemble filaments. When the myosin is
phosphorylated, its shape changes to the extended 6S form
and filaments are assembled (Onishi and Wakabayashi,
1982; Trybus et al., 1982; Craig et al., 1983). Thus, the fila-
ments formed from the phosphorylated myosin become
unstable upon dephosphorylation of the RLC and, as a re-
sult, easily fall apart.
These in vitro properties of smooth muscle myosin fila-
ments are of particular interest when we observe the per-
sistent nature of thick filaments in smooth muscle cells.
Their myosin is repeatedly subject to cycles of phosphory-
lation and dephosphorylation in response to contraction,
followed by relaxation (for review, see Stull et al., 1991;
Somlyo and Somlyo, 1994). However, there is no sign of
assembly and disassembly of thick filaments, indicating
that they are stable (Somlyo et al., 1981; Cooke et al.,
1989; Xu et al., 1996). By raising an mAb to the 10S form,
Horowitz et al. (1994) examined the intracellular form of
myosin. The concentration of 10S myosin was very low, re-
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gardless of contraction and relaxation states, most of the
myosin being in the 6S form. Therefore, myosin filaments
are expected to be stabilized as thick filaments by myosin-
binding proteins in the cell. The first examination of this
suggestion was by Shirinsky et al. (1993), who observed
that telokin binds to dephosphorylated smooth muscle
myosin to stimulate myosin assembly. However, telokin is
not present in all smooth muscle cells (Gallagher and Her-
ring, 1991), indicating the presence of another myosin-
binding protein(s) with a similar role in the cell.
We were interested in this indication and adopted a
strategy to purify myosin-binding proteins from skeletal
muscles (Starr and Offer, 1971). We chose a crude prepa-
ration of smooth muscle myosin as a starting material and
purified a protein of 38 kD that bound to myosin, causing
filament assembly.
 
Materials and Methods
 
Preparation of Proteins
 
Fresh chicken gizzards were minced within 2 h of killing, and kept frozen
at 
 
2
 
80
 
8
 
C until use. Proteins other than myosin were purified from the fro-
zen mince, unless otherwise specified. Dephosphorylated myosin was pu-
rified from chicken gizzard according to Ebashi (1976) with modifications
(Ikebe and Hartshorne, 1985a) and used as unphosphorylated myosin. We
checked that myosin preparations did not contain the 38k myosin-assem-
bling protein by SDS-PAGE or Western blotting. When required, myosin
was phosphorylated with myosin light chain kinase (MLCK) in the pres-
ence of Ca
 
2
 
1
 
 and calmodulin (Okagaki et al., 1991). Rod, light meromyo-
sin (LMM), and heavy meromyosin (HMM) of gizzard myosin were pre-
pared proteolytically as described (Ikebe and Hartshorne, 1985b; King et
al., 1995). Myosin was also purified from chicken breast muscle and bo-
vine heart and used as skeletal and cardiac myosin, respectively (Okagaki
et al., 1993). In this paper, myosin denotes smooth muscle myosin unless
otherwise mentioned. MLCK, telokin, and tropomyosin were purified
from chicken gizzard according to Hayakawa et al. (1994), Ito et al. (1989),
and Ishikawa et al. (1989), respectively. Monomeric actin was purified
from chicken breast muscle and used as actin filaments after polymeriza-
tion (Okagaki et al., 1991). The concentration of actin filaments was ex-
pressed as that of monomeric actin.
 
Preparation of the 38k Protein
 
Following our experience with C-protein, a myosin-binding protein of
skeletal muscle (Okagaki et al., 1993), we used a crude myosin prepara-
tion (see below) as the starting material. From this, we purified a protein
of 38 kD in SDS-PAGE using myosin-assembling activity under dark-field
microscopy (see below) as a probe. All columns (see below) were incorpo-
rated into a high performance liquid chromatography system (model
L-6200; Hitachi).
The mince of chicken gizzard was thawed, suspended in 3 vol of buffer
containing 30 mM NaCl, 1 mM EDTA, 20 mM Tris-HCl, pH 7.5, and 1 mM
DTT, and precipitated by centrifugation at 1,000 
 
g 
 
for 10 min. This wash-
ing was repeated four times to remove soluble proteins. The washed
mince was homogenized in 3 vol of extraction buffer (0.1 M NaCl, 5 mM
ATP, 2 mM EDTA, 20 mM Tris, pH 7.5, 1 mM DTT, 0.5 mM PMSF, and
0.5 
 
m
 
g/ml leupeptin) using a cooking mixer. From the homogenate, the
38k protein was extracted together with myosin for 40 min with occasional
mixing on ice. The homogenized muscle was centrifuged at 1,000 
 
g 
 
for 40
min. After centrifugation, supernatants were pooled and the extraction
procedure was repeated on the precipitate. The second supernatant was
mixed with the pool (for SDS-PAGE, see Fig. 1, lane 2). The 38k protein
could be extracted from the muscle with 2 mM ATP, but higher concen-
trations of ATP increased the yield of the protein. Higher salt solutions
(0.2–0.3 M NaCl) also extracted more of the 38k protein from the muscle,
but also increased contamination. Thus, we adopted the above extraction
buffers. NaCl was added to the pooled extracts to increase its concentra-
tion to 0.3 M. The mixture was further centrifuged at 100,000 
 
g
 
 for 2 h to
precipitate actin filaments and actin-associated proteins. We denote this
supernatant as partially purified myosin in this paper (Fig. 1, lane 3). The
 
supernatant was subjected to stepwise ammonium sulfate fractionation.
Aliquots of each step of the fractionation were desalted with Biogel P-6
(BioRad Laboratories), equilibrated with buffer A (1 mM ATP, 2 mM
MgCl
 
2
 
, 0.1 M NaCl, 20 mM Tris-HCl, pH 7.5, 1 mM DTT, and 0.5 mM
PMSF) and mixed with unphosphorylated myosin at a final concentration
of 0.2 
 
m
 
M in buffer A. The mixtures were subjected to the dark-field mi-
croscopy to examine myosin-assembling activity (see Centrifugation As-
say). The fractions precipitated at between 55 and 80% saturation (Fig. 1,
lane 4) contained the myosin-assembling activity. The fractions were dis-
solved in buffer B (20 mM Tris-HCl, pH 7.5, 1 mM DTT, 0.5 mM PMSF, and
0.5 
 
m
 
g/ml leupeptin), the volume of which was selected to adjust its con-
ductivity to be as low as that of 0.2 M NaCl. Then the solution was clari-
fied by centrifugation at 100,000 
 
g 
 
for 2 h. The supernatant was applied to
DEAE Toyopearl 650M (Tosoh), equilibrated with buffer B supple-
mented with 0.2 M NaCl, followed by elution with a linear gradient of
NaCl from 0.2–0.5 M. Aliquots of each eluate were desalted and tested for
myosin-assembling activity as described. The activity was detected in the
fractions eluted with 0.3–0.4 M NaCl. The fractions containing activity
were composed of polypeptides of 38 kD, 17 kD, and minor contaminants
(Fig. 1, lane 5). They were pooled, concentrated with Centricon-30 (Milli-
pore), and applied to a Superdex HR75 column (Amersham-Pharmacia)
equilibrated with buffer B supplemented with 0.3 M NaCl. Fractions cor-
responding to 15–30 kD, as estimated by a molecular weight marker for
gel filtration (Amersham-Pharmacia), showed the myosin-assembling ac-
tivity. The major protein band of these fractions was 38 kD on SDS-
PAGE (Fig. 1, lane 6). We used this fraction for the most of biochemical
experiments. During column chromatography, the 38k protein often de-
graded to polypeptides of 20 and 17 kD if leupeptin was absent. We rou-
tinely obtained 0.8–1.0 mg of the 38k protein from 200 g of gizzard.
 
Observation of Myosin Filament Assembly by the
38k Protein
 
Myosin at 0.2 
 
m
 
M was mixed with the 38k protein or the 38k protein-con-
taining fractions in buffer A and incubated at room temperature for 30
min. A drop of the mixture was mounted on a glass slide, sealed with a
coverslip, and observed with a dark-field microscope (Okagaki et al.,
1991). Myosin filaments were detected as small spots of uniform size. The
fine structure of myosin filaments was confirmed by EM. A drop of the
above mixture was placed on a grid coated with collodion and carbon,
stained with l% uranyl acetate, and observed with JEM 100C electron mi-
croscope operated at 80 kV.
 
Centrifugation Assay for Myosin-assembling,
Myosin-binding, and Actin-binding Activities
 
Myosin (1.1 
 
m
 
M), either in phosphorylated or unphosphorylated form,
was mixed with various concentrations of the 38k protein in buffer A, and
the mixture was incubated at room temperature for 30 min, followed by
centrifugation at 100,000 
 
g 
 
for 40 min. The supernatant and precipitate
were separately subjected to SDS-PAGE. The SDS-PAGE gels were
Figure 1. Purification of the
38k protein. Aliquots of sam-
ples from the following puri-
fication steps were applied to
SDS-PAGE: 1, Total homo-
genate of gizzard; 2, myosin
extracted from gizzard; 3,
crude myosin preparation
(supernatant in the presence
of 0.3 M NaCl and 5 mM
ATP); 4, ammonium sulfate
precipitate of partially puri-
fied myosin preparation at
55–80% saturation; 5, the
fraction of DEAE Toypearl
650M with the highest myo-
sin-assembling activity; and 6, the active principle eluted from
Superdex HR75. The 38k to the right of lane 6 denotes the band
of the 38k protein. For details, see Materials and Methods. 
Okagaki et al. 
 
A Myosin-assembling Protein from Smooth Muscle
 
655
 
stained with Coomassie brilliant blue and the protein bands were densi-
tometrically scanned. The density of the protein band was calculated by
NIH image (version 3.0). The densities of myosin heavy chain (MHC),
the 38k protein, and telokin were considered, respectively, as assem-
bled myosin, the 38k protein bound to myosin, and telokin bound to
myosin.
The relationship of the amount of the 38k protein bound to unphos-
phorylated myosin is shown (see Fig. 3 e). Unphosphorylated myosin re-
mains in the supernatant if insufficient 38k protein is added. Therefore, it
is possible that part of the 38k protein remains in the supernatant, despite
its binding to myosin. However, we believe that this is unlikely and that
the 38k protein bound to unphosphorylated myosin is mostly recovered in
the precipitate (compare open and closed circles in Fig. 3 e). The binding
of 5.4 
 
m
 
M of 38k protein to 10 
 
m
 
M actin filaments in the presence and ab-
sence of tropomyosin was examined by a similar centrifugation assay (Ish-
ikawa et al., 1989).
The centrifugation assay of the 38k protein bound to insoluble myosin
fragments was also performed in a similar way. Various concentrations of
the 38k protein were mixed with 1.1 
 
m
 
M rod or LMM in buffer A, centri-
fuged, and analyzed as above. The interaction of the 38k protein to solu-
ble myosin-fragment of HMM was examined by the gel filtration (see Fig.
5, inset), i.e., 8.5 
 
m
 
M HMM and 40 
 
m
 
M 38k protein in 300 
 
m
 
l buffer A was
applied to the column Superose 6 (Amersham-Pharmacia).
The molecular weights used for calculation based upon their primary
structure are 440,000 for MHC, 24,000 for the 38k protein (or human p32,
its human isoform, see below), 18,000 for telokin, 42,000 for actin, and
35,000 for tropomyosin. The molecular weights of myosin fragments used
for calculation are: 250,000, 150,000, and 260,000 for rod, LMM, and
HMM, respectively.
 
Determination of Partial Amino Acid Sequence
 
The partial amino acid sequence of the 38k protein was determined after
cleavage with 
 
Staphylococcus
 
 V8 protease (Pierce Chemical Co.). The
weight ratio of the 38k protein to V8 protease was 100:1 and the digestion
was for 30 min at room temperature at the boundary between the stacking
and running gels of SDS-PAGE. The 38k protein was degraded to only
two bands of 20 and 17 kD, and smaller fragments were not obtained by
prolonged digestion of up to 1 h. The cleaved protein was subjected to
SDS-PAGE and then electrotransferred to poly vinyl demethyl fluorate
(PVDF) membrane, the bands of 38 (uncleaved protein), 20, and 17 kD
were excised and sequenced (476A; Applied Biosystems). Two sequences
were obtained; LHTEGDKAFAQFLTDEI from the 38- and the 20-kD
bands, and REVSFQPTGESD from the 17-kD band.
 
cDNA Cloning of the 38k Protein
 
Total RNA was extracted from fresh chicken gizzard by homogenizing the
tissue in TRIZOL reagent (Life Technologies) using a polytron homoge-
nizer. mRNA was then purified with Oligotex-dT30 
 
,
 
super
 
. 
 
(Japan
Roche) according to the manufacturer’s protocol. cDNA was synthesized
by First-Strand cDNA-synthesis kit (Amersham-Pharmacia) using oligo-
dT adapter primer (RR012A; Takara). Based on the above two partial
amino acid sequences, we designed two primers: p1, 5
 
9
 
-CA(CT)AC
(ATC)GA(AG)GG(ATC)GA(CT)AA(AG)GC(ATC)TT(CT)GC(ATC)
CA(AG)TT(CT)-3
 
9
 
; and p2R, 5
 
9
 
-(AG)TC(CT)TC(ACGT)TC(GAT)
CC(GAT)GT(ACGT)(GT)(AT)(CT)TG(AG)(GC)(AC)(GAT)(AT)
(GC)(ACGT)(GC)C-3
 
9
 
. PCR was performed with these primers (30 cy-
cles of 95
 
8
 
C [1 min], 55
 
8
 
C [2 min], 72
 
8
 
C [3 min]) using the above cDNA as
template, and a product of 400 bp as examined by agarose gel electro-
phoresis was obtained. This PCR product, denoted as S1, was subcloned
into the pGEM-T Easy vector system (Promega) and the nucleotide se-
quence of the cDNA clones were determined by the dideoxy chain ter-
mination method with Dye Primer Cycle Sequencing Kit (Applied-Bio-
systems) using an automated DNA sequencer (Prism 377A; Applied
Biosystems). To extend cDNA sequence in the 3
 
9
 
-direction, we performed
3
 
9
 
-RACE (Frohman et al. 1988). Based on the 3
 
9
 
-end sequence of S1, we
designed the primer p4, 5
 
9
 
-GAGGAGGAAAGTGACATTTTCAC-3
 
9
 
.
Using p4 and the oligo-dT adapter as primers, and the above cDNA as
template, PCR was performed as described above. A 700-bp product, de-
noted as S2, containing a termination codon and poly-A sequence, was ob-
tained. The PCR product was subcloned into the pGEM-T Easy vector
and its nucleotide sequence was determined as described above. The
cDNA fragment of the 38k protein, denoted as S3, was obtained by PCR
using primers corresponding to the sequences of the 5
 
9
 
-end of S1, 5
 
9
 
-
GATTCACACGGAGGGGGATAAAGCG-3
 
9
 
; and the 3
 
9
 
-end of the
 
coding region of S2, 5
 
9
 
-GAGCACTGCTTTCCTAACCTACTGACAT-
TTGAC-3
 
9
 
. The above cDNA was used as template. The PCR product
was subcloned to pGEM-T Easy vector.
The gizzard cDNA library, synthesized by priming with oligo-dT using
TimeSaver cDNA synthesis kit (Amersham-Pharmacia), was constructed
in 
 
l
 
ZAPII (Stratagene) vectors. To confirm sequence of the 5
 
9
 
-end of S3,
cDNA clone of the 38k protein was obtained by screening the gizzard
cDNA library (2 
 
3
 
 10
 
5
 
 plaques) by plaque hybridization with the direct la-
beling of the above PCR product of S3 with alkaline phosphatase by Alk-
Phos Direct labeling kit (Amersham-Pharmacia). The detection was
performed with CDP-Star chemiluminescent (Tropix Inc). pBluescript
SK(
 
2
 
) (Stratagene) carrying cDNA inserts was prepared by in vivo exci-
sion from the 
 
l
 
ZAPII vectors. Both strands were completely sequenced
by the same method as described above. The nucleotide sequence data re-
ported in this paper will appear in the GenBank/EMBL/DDBJ nucleotide
sequence databases with accession number AB029946.
 
Expression of the Human p32 and the 38k Protein
 
As will be described, the 38k protein had a high sequence homology to hu-
man p32. pT7 plasmid containing cDNA encoding human p32, a gift from
Dr. A. Krainer (Cold Spring Harbor Laboratory, NY), was transformed
into 
 
Escherichia coli
 
 strain BL21(DE3) (Krainer et al., 1991). Cells ex-
pressing human p32 after induction with 1 mM isopropylthio-
 
b
 
-
 
D
 
-galacto-
side (IPTG) were collected by centrifugation at 10,000 
 
g 
 
for 10 min and re-
suspended in 0.3 M NaCl, 20 mM Tris, pH 7.5, 1 mM DTT, 0.5 mM PMSF,
and 0.5 
 
m
 
g/ml leupeptin. The cells were frozen, thawed, sonicated (SONI-
FIER 200; Branson) and centrifuged at 10,000 
 
g 
 
for 30 min. Human p32
was purified from the supernatant by ammonium sulfate fractionation, fol-
lowed by DEAE chromatography as described for the purification of the
38k protein from chicken gizzard. The recombinant protein was used in
the present experiments as human p32.
Constructs of truncated forms of the 38k protein were made by PCR
reactions using primers containing a 5
 
9
 
 NcoI restriction site including
ATG and a 3
 
9
 
 EcoRI site. The primers used were: M1, 5
 
9
 
-GCATGCCA-
TGGACACGGAGGGGGATAAAGC-3
 
9
 
; M2, 5
 
9
 
-GCATGCCATGG-
GCATCCCCCCCGCGGTGG-3
 
9
 
; M3, 5
 
9
 
-CGGAATTCCTATTCTC-
CGGTGGGCTGAAAGC-3
 
9
 
; M4, 5
 
9
 
-CGGAATTCCTACTGACATT-
TGACAAAGC-3
 
9
 
; M5, 5
 
9
 
-GCATGCCATGGCGACTCCGAACTTC-
GTTGTGGAGG-3
 
9
 
; M6, 5
 
9
 
-GCATGCCATGGATTGGAAGGACAC-
CAACTACACC-3
 
9
 
; M7, 5
 
9
 
-GCATGCCATGGCCAAAGTGTCCGGC-
3
 
9
 
; and M8, 5
 
9
 
-CCGGAATTCCTATGCAGTGCTGAGCTCAAT-3
 
9
 
.
The cDNA fragment of S3 (see above) was used as a template for the
PCR reactions. The primers were used in the following combinations: full-
length protein (1–207 residues), M1 and M4; 
 
D
 
N28 (29–207 residues), M7
and M4; 
 
D
 
N63 (64–207 residues), M2 and M4; 
 
D
 
N88 (89–207 residues),
M6 and M4; 
 
D
 
NC (64–141 residues), M2 and M3; 
 
D
 
C66 (1–141 residues),
M1 and M3; and 
 
D
 
C20 (1–187 residues), M1 and M8. PCR was as de-
scribed, PCR products were cut with NcoI and EcoRI, and subcloned to
the NcoI/EcoRI site of pET21d (Novagen). These plasmids were trans-
formed into BL21(DE3) and the truncated and full-length forms of the
38k protein were expressed as described. The expressed proteins were pu-
rified as described above and used as the recombinant 38k protein and the
truncated 38k protein. The 38k protein denotes native protein purified
from smooth muscle.
 
Immunochemical Experiments
 
Rabbits and guinea pigs were injected with human p32. Their sera were
used as anti-38k protein antibodies after affinity purification through
NHS-sepharose (Amersham-Pharmacia) conjugated with human p32. For
Western blotting, samples after SDS-PAGE were electrotransferred onto
PVDF membrane to react with the anti-38k protein antibody. Immunore-
action was detected using goat anti–rabbit IgG conjugated with HRP
(55689; Cappel) as secondary antibody, coupled with the ECL system
(Amersham-Pharmacia).
To estimate the content of the 38k protein in various smooth muscle
tissues, they were excised from a freshly killed adult rat, frozen in liquid
nitrogen, broken into small chips with a frozen air hammer, and then
mixed with an SDS-containing buffer for SDS-PAGE. The mixture was
subjected to Western blotting, together with specified amounts of human
p32 as a standard. Intensities of the immunoreacted bands were quantified
by densitometry as described above.
For indirect immunofluorescence microscopy, we used the smooth
muscle cell line, AC01, recently established from mouse aorta (Ohmi et al.,
1997). This cell line appears in the Japanese Collection of Research Bio- 
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sources Cell Bank. Cells were fixed with 3.5% formaldehyde, 1% glutaral-
dehyde, and 0.1% Triton X-100 on ice for 30 min, washed with PBS
several times, and reacted with the anti-38k protein antibody or the fol-
lowing commercial antibodies: smooth muscle MHC polyclonal, BTI564
(Biochemical Technologies Inc.); desmin polyclonal, PS031 (SANBIO);
anti–
 
a
 
-actin monoclonal, A2547 (Sigma Chemical Co.); and anti–
 
b
 
-actin
mAbs, A5441 (Sigma Chemical Co.). To visualize the localization of
proteins, the specimen was treated with the following secondary anti-
bodies; goat anti–rabbit IgG conjugated with FITC (55641; Cappel),
goat anti–rabbit IgG conjugated with rhodamine (55674; Cappel), goat
anti–mouse IgG conjugated with rhodamine (55539; Cappel), and goat
anti–guinea pig IgG conjugated with FITC (57000; Cappel). For visual-
ization of mitochondria, cells were stained with MitoTracker Red
CMXRos (Molecular Probes) before fixation according to the manufac-
ture’s protocol.
To demonstrate the colocalization of the 38k protein/myosin and that
of the 38k protein/mitochondria in the smooth muscle cells (see Fig. 7),
they were subjected to the double staining with anti-38k protein antibody,
and with anti-MHC antibody or with MitoTracker Red CMXRos. Each
pair of images were incorporated into Adobe Photoshop (version 4.0) and
then processed to create product images (see Fig. 7, c and f).
 
Results
 
Myosin Filaments Formed by the 38k Protein
 
Purified myosin hardly assembled to form filaments when
unphosphorylated (Fig. 2 a). However, when the 38k pro-
tein was present, unphosphorylated myosin could form fil-
aments (Fig. 2 c). The preparation of the 38k protein did
not show kinase activity for myosin when incubated with
myosin in the presence of ATP for 1 h (data not shown).
Thus, the myosin assembling activity could not be due to
an elevation of phosphorylation level of myosin, but to an
inherent property of the 38k protein.
As shown in the histograms (Fig. 2, e and f), the length
of assembled filament was from 0.4–1.2 
 
m
 
m and the diame-
ter was 
 
z
 
20 nm. The length and diameter of these fila-
ments were almost identical to those of filaments formed
by phosphorylated myosin without the 38k protein (Fig. 2
b). The average length of the filaments formed with the
38k protein was 0.65 
 
6 
 
0.15 
 
m
 
m, SEM (
 
n
 
 5 
 
150; Fig. 2 e,
arrow), whereas that of phosphorylated myosin was 0.65 
 
6
 
0.16 
 
m
 
m, SEM (
 
n
 
 5 
 
150; Fig. 2 F, arrow).
Thus, the 38k protein keeps myosin in filaments, even
though myosin is unphosphorylated. As will be discussed
later, we expect that the 38k protein could prevent disas-
sembly of thick filaments when myosin is dephosphory-
lated by phosphatase in vivo.
 
Quantification of Myosin-binding and
Myosin-assembling Activities of the 38k Protein
 
To quantify the myosin filament assembling activity of the
38k protein, unphosphorylated myosin was incubated in
the presence of various concentrations of the 38k protein
and the assembled unphosphorylated myosin was precipi-
tated by centrifugation. In the absence of the 38k protein,
 
.
 
90% of unphosphorylated myosin remained in the su-
pernatant after centrifugation (Fig. 3 a, lanes 1 and 2). The
amount of unphosphorylated myosin recovered in the pre-
cipitate was increased by increasing concentration of the
38k protein, as shown by the open circles in Fig. 3 d. Con-
centration to give half-maximal assembly was 0.8 
 
6 
 
0.2 
 
m
 
M,
SEM (
 
n
 
 5 
 
3), with the maximal effect being observed in
the presence of 
 
z
 
3 
 
m
 
M of the 38k protein. The amount of
 
the 38k protein precipitated together with unphosphory-
lated myosin also increased, as is shown by open circles in
Fig. 3 e. The maximum amount of the 38k protein bound
to 1.1 
 
m
 
M myosin was 1.2 
 
6 
 
0.1 
 
m
 
M, SEM (
 
n
 
 5 
 
3) and the
concentration giving half-maximal binding was 1.7 
 
6 
 
0.2 
 
m
 
M,
SEM (
 
n
 
 5 
 
3).
The binding experiment was also performed using phos-
phorylated myosin. Phosphorylated myosin could assem-
ble into filaments without the 38k protein, as was seen by
microscopic observation (Fig. 2 b). When quantified by
the centrifugation assay (Fig. 3 b), 
 
.
 
90% of the myosin
was sedimented (Fig. 3 b, lane 2). There was no obvious ef-
fect on the assembly when the 38k protein was added (Fig.
3 d, closed circles).
The closed circles in Fig. 3 e show the binding of the 38k
protein to phosphorylated myosin. Similar to unphosphor-
ylated myosin, the half-maximal binding was observed at
1.4 
 
6 
 
0.2 
 
m
 
M, SEM (
 
n
 
 5 
 
3). The binding to phosphory-
lated myosin is distinct from telokin, which does not show
any binding to phosphorylated myosin (Shirinsky et al.,
Figure 2. Electron micrographs of myosin filaments assembled
with the 38k protein. In the absence of the 38k protein, unphos-
phorylated myosin (0.2 mM) did not form filaments (a). How-
ever, they were formed from phosphorylated myosin in the ab-
sence of the 38k protein (b). Unphosphorylated myosin (0.2 mM)
was assembled by 0.55 mM of the 38k protein (c). Filaments
formed by 0.2 mM unphosphorylated myosin with 0.69 mM telo-
kin (d). Length distribution of filaments formed by 0.2 mM un-
phosphorylated myosin with 0.55 mM of the 38k protein (e) and
that of filaments formed from phosphorylated myosin in the ab-
sence of the 38k protein (f). These histograms were obtained by
measurement of the length of 150 filaments. Arrows in e and f in-
dicate average length.Okagaki et al. A Myosin-assembling Protein from Smooth Muscle 657
1993). The distinction may derive from the difference in
the binding site of myosin (see Fig. 5).
The binding of the 38k protein to skeletal muscle myo-
sin was much weaker than that of smooth muscle myosin
(see Fig. 5). The same was observed with cardiac myosin
(see Fig. 5). These observations indicate that its binding is
specific for smooth muscle myosin and agree with the ob-
servation that it is absent from skeletal muscle cells (see
Fig. 6 d).
To examine whether the protein can bind to myofibrillar
components other than myosin, we studied its binding to
actin filaments in the presence and absence of tropomyo-
sin. The 38k protein bound to neither actin filaments (Fig.
3 c, lanes 3 and 4) nor actin filaments associated with tro-
pomyosin (Fig. 3 c, lanes 5 and 6).
Absence of Cross-Talk between the 38k Protein
and Telokin
To determine whether the 38k protein and telokin share
the same binding site(s) in the myosin molecule, we al-
lowed the 38k protein to compete with telokin for myosin
binding. We initially confirmed that telokin induced as-
sembly of unphosphorylated myosin under our experi-
mental conditions (Figs. 2 d and 4 a). The effect was satu-
rated when .2 mM of telokin was mixed with 1 mM of
myosin. To this mixture, various amounts of the 38k pro-
tein were added. As shown in Fig. 4 c, even when the as-
sembly was maximally induced by telokin, the addition of
the 38k protein further stimulated assembly. The maximal
binding of the 38k protein to myosin did not change
whether or not telokin was present (Fig. 4 d, open circles).
Accordingly, the maximal binding of telokin to myosin
was not affected by the 38k protein (Fig. 4 d, closed cir-
cles).
The possibility that the 38k protein binds directly to telo-
kin without affecting its myosin-binding activity can be re-
jected because telokin did not interact with the 38k pro-
tein when the interaction was examined by gel filtration
(data not shown).
Figure 3. Sedimentation assay of myosin assembly. Myosin (1.1
mM) and the 38k protein were mixed in buffer A, and the mixture
was allowed to assemble. The assembled myosin was precipitated
by centrifugation and quantified. a, SDS-PAGE pattern of super-
natants (1, 3, and 5) and precipitates (2, 4, and 6) after centrifuga-
tion of the mixture of unphosphorylated myosin and the 38k pro-
tein. Concentrations of the 38k protein were 0 mM (1 and 2),
1.4 mM (3 and 4), and 5.4 mM (5 and 6). b, SDS-PAGE pattern of
supernatants (1, 3, and 5) and precipitates (2, 4, and 6) from the
sedimentation assay with phosphorylated myosin. Concentra-
tions of the 38k protein were 0 mM (1 and 2), 1.4 mM (3 and 4),
and 5.4 mM (5 and 6). c, SDS-PAGE pattern of supernatants (1,
3, and 5) and precipitates (2, 4, and 6) from the binding assay of
the 38k protein to actin filaments. Actin filaments alone at 10 mM
(1 and 2); 10 mM actin filaments and 5.4 mM of the 38k protein (3
and 4); and 10 mM actin filaments, 1.4 mM tropomyosin, and
5.4 mM of the 38k protein (5 and 6). d, The amount of assembled
myosin was plotted against concentration of the 38k protein
mixed with 1.1 mM myosin. Open and closed circles indicate un-
phosphorylated and phosphorylated myosin, respectively. e, The
amount of the 38k protein bound to myosin was plotted against
the 38k protein mixed with 1.1 mM myosin. Open and closed cir-
cles denote the unphosphorylated and phosphorylated myosin,
respectively. MHC, 38k, A, a-TM, and b-TM denote the bands of
MHC, the 38k protein, actin, and a- and b-tropomyosins, respec-
tively.
Figure 4. Relationship in myosin-assembling activity between
the 38k protein and telokin. a, Effect of telokin on 1.1 mM myosin
assembly. The amount of assembled myosin was plotted against
telokin concentration. Open and closed circles indicate unphos-
phorylated and phosphorylated myosin, respectively. b, Amount
of telokin coprecipitated with 1.1 mM myosin. The amount of
telokin bound to myosin was plotted against telokin concentra-
tion. Open and closed circles indicate unphosphorylated and
phosphorylated myosin, respectively. c, Myosin assembly in the
presence of telokin and the 38k protein. In the presence of a satu-
ration of telokin (3.5 mM, as judged from a), various concentra-
tions of the 38k protein were mixed with 1.1 mM unphosphory-
lated myosin and then the mixture was centrifuged to precipitate
myosin filaments. The amount of assembled myosin was plotted
against concentration of the 38k protein. d, In the experiment of
c, the amount of the 38k protein (open circles) and that of telokin
(closed circles) bound to myosin filaments was plotted against
concentration of the 38k protein.The Journal of Cell Biology, Volume 148, 2000 658
Binding of the 38k Protein to Myosin Fragments
To examine which portion of the myosin molecule the 38k
protein binds to, we allowed it to bind to rod, LMM, or in-
tact myosin. The fragments themselves are insoluble and
easy to precipitate under the conditions for myosin bind-
ing. As shown in Fig. 5, the 38k protein could bind to
LMM and rod, as well as myosin, although the maximum
extent of binding to LMM was lower than those to rod and
to myosin.
We then mixed the 38k protein with HMM of a soluble
myosin fragment, and the mixture was subjected to the gel
filtration. Both proteins were eluted in the different frac-
tions, and their interaction was not detected (Fig. 5, inset).
Taken together, the above data indicate that the major
site of the binding of the 38k protein should be in LMM.
The indication is compatible with the absence of cross-talk
between the 38k protein and telokin, because telokin
binds to myosin at subfragment-2 (Shirinsky et al., 1993)
Both NH2-terminal and COOH-terminal Parts of the 
38k Protein Are Required for Myosin Assembly
The myosin-assembling activity of the recombinant 38k
protein was confirmed by observing that myosin filaments
formed in its presence were the same as those formed by
the native 38k protein under EM (data not shown). To test
which part of the 38k protein contributes to the myosin-
assembling activity, we produced several constructs of de-
letion mutants comparable to those of telokin (Silver et
al., 1997).
As shown in Table I, when full-length, recombinant 38k
protein at 4 mM was mixed with 1.1 mM myosin in either
phosphorylated or unphosphorylated form, the amount of
the 38k protein bound to the myosin was z1.0 mM. How-
ever, the NH2-terminal–deleted mutants DN28, DN63, and
DN88 did not bind to phosphorylated or unphosphory-
lated myosin. Similarly, the COOH-terminal–deleted mu-
tants, DC20 and DC66, could not bind to either type of
myosin. Thus, deletion of the NH2-terminal 28 or COOH-
terminal 20 amino acid residues of the 38k protein com-
pletely abolished the interaction with myosin. The signifi-
cance of these data will be discussed below with reference
to the crystal structure of human p32, which was published
recently by Jiang et al. (1999).
Comparison of the Amino Acid Sequences of the 38k 
Protein and Human p32
Two partial amino acid sequences (LHTEGDKAFAQF-
LTDEI and REVSFQPTGESD) were obtained by cleav-
age with V8 protease. The former sequence was also ob-
tained from undigested 38k protein, suggesting that the
sequence is at the NH2 terminus of the protein. The amino
acid sequence deduced from the cDNA sequence of the
38k protein (see Materials and Methods) is shown in Fig. 6
a. The calculated molecular weight was 23,681. Compari-
son with the GenBank/EMBL/DDBJ data base revealed
that the sequence is highly homologous to human p32,
which was originally identified as a protein copurified with
human splicing factor-2 (Krainer et al., 1991; Honore et al.,
1993). Alignment of the 38k protein to p32 showed that
78% of the amino acid sequence of chicken 38k protein
was identical to that of human p32. Mouse YL2 (Luo et al.,
1994), a homologue of p32, was also highly homologous
(74%) with the 38k protein.
Characterization of Expressed Human p32 as a 
Homologue of the 38k Protein
Human p32 is known to contribute to various cellular
functions, such as splicing of pre-mRNA (Krainer et al.,
1991; Mayeda et al., 1992; Honore et al., 1993), binding of
rev protein of the HIV virus to enhance duplication of the
genomic DNA of the virus (Luo et al., 1994; Tange et al.,
1996) and cell surface receptors for complements (Ghebre-
hiwet et al., 1994; Lim et al., 1996), and for high molecular
weight kininogen (Joseph et al., 1996). However, to our
Figure 5. The amounts of the
38k protein coprecipitated by
binding to myosin and its
fragments, and striated mus-
cle myosins. The assembly of
unphosphorylated myosins
was observed only in the
presence of the 38k protein
(see Fig. 3). The assembly of
rod, LMM, skeletal, and car-
diac myosins do not require
the 38k protein. About 95%
of total amount of rod, 85%
of that of LMM, 90% of that of skeletal and cardiac myosins
could be precipitatable under our assay conditions. The 38k pro-
tein was mixed with 1.1 mM of various types of myosin and its
fragments and centrifuged to coprecipitate with them. The
amounts of the 38k protein recovered in the precipitate were
quantified by the densitometry. Rod (open circles), LMM (closed
circles), unphosphorylated myosin (open triangles), skeletal
(open squares), and cardiac myosins (closed squares). Data are
from the average of two sets of independent experiments. Inset,
Gel filtration pattern of the mixture of HMM and the 38k pro-
tein. The mixture of 8.5 mM HMM and 40 mM 38k protein in 300
ml buffer A was applied to Superose 6 equilibrated with buffer A
and eluted with buffer A in a flow rate of 0.5 ml/min. A280 in arbi-
trary unit (ordinate) was plotted against elution time (abscissa).
HMM and the 38k protein was separately eluted in the peak at 31
and 35 min, respectively. SDS-PAGE patterns of peak fractions
of HMM (left) and the 38k protein (right) were also shown. Ar-
rowheads indicate HMM (H) and the 38k protein (38).
Table I. Binding of the 38k Protein and its Deletion Mutants
to Myosin
Unphosphorylated 
myosin
Phosphorylated 
myosin
Full-length (1–207) 1.00 1.09
DN28 (29–207) 0.02 0.02
DN63 (64–207) 0.01 0.02
DN88 (89–207) 0.01 0.01
DNC (64–141) 0.00 0.00
DC66 (1–141) 0.00 0.01
DC29 (1–187) 0.02 0.03
Mutants of the 38k protein (4.0 mM) were mixed with myosin (1.1 mM) in buffer
A and precipitated with myosin as described in Materials and Methods.
Amounts of the 38k protein or its mutants recovered in the precipitate were
quantified and expressed in micromoles (mM). Data are the average of two sets
of independent experiments. The numbers in parentheses refer to the number of
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knowledge, it has not yet been characterized as a cytoskel-
etal protein.
To clarify any functional difference between the 38k
protein and human p32, we examined assembly of myosin
by human p32. As shown in Fig. 7 a, it induced formation
of filaments of unphosphorylated myosin, as well as the
38k protein did. The length distribution of the myosin fila-
ments (Fig. 7 b) was similar to that of the 38k protein (Fig.
2 e), the average length of the filaments being 0.69 6
0.16 mm, SEM (n 5 150; Fig. 7 b, arrow). The myosin-
assembling activity was also quantified by the centrifuga-
tion assay. The concentration of human p32 required to give
half-maximal assembly estimated from Fig. 7 c was 0.9 6
0.2 mM, SEM (n 5 3), with the concentration giving half-
maximal binding at 1.8 6 0.2 mM, SEM (n 5 3). These fig-
ures are similar to those of the 38k protein (compare Fig. 7
c with Fig. 3 d). Thus, the human p32 appears to possess
similar activity to that of the 38k protein.
We stained the blot of SDS-PAGE of total homogenate
of chicken gizzard and the purified 38k protein with anti-
38k protein antibody. As shown in Fig. 6 c, the sole immu-
noreacting band is 38 kD. Because the antibody was raised
against human p32 (see Materials and Methods), we con-
clude that the human p32 is a homologue of the 38k protein.
Distribution of the 38k Protein in Smooth
Muscle Tissues
To examine the expression of the 38k protein in various
Figure 6. Amino acid sequence of the 38k protein deduced from
cDNA sequencing. a, The sequences of the 38k protein as de-
noted by chicken 38k (GenBank/EMBL/DDBJ accession number
AB029946) are aligned with human p32 (GenBank/EMBL/DDBJ
identification number, g338043) and mouse YL2 (GenBank/
EMBL/DDBJ identification number, g743485). Two sequences
of the 38k protein determined by direct amino acid sequencing
are underlined. Hatched sequences indicate identical amino ac-
ids. b, Expression of human p32 in E. coli. SDS-PAGE pattern of
total cell homogenate before (1) and after (2) IPTG induction.
Purified human p32 (3) and the 38k protein (4). c, Immunoblot-
ting with anti-38k protein antibody. Total homogenate of chicken
gizzard (1, 2, and 3) and the purified 38k protein (4, 5, and 6).
Protein staining (1 and 4) and immunostaining with anti-38k pro-
tein antibody (2 and 5), and with preimmune serum (3 and 6).
38k and h-p32 denote the bands of the 38k protein and human
p32, respectively. d, Expression of the 38k protein in various
muscles. The 38k protein was detected in the homogenate of var-
ious smooth muscle tissues of rat. Lanes: esophagus (1), stomach
(2), duodenum (3), small intestine (4), cecum (5), rectum (6),
uterus (7), aorta (8), air way (9), skeletal muscle (10), and cardiac
muscle (11). 10 mg of each homogenate were applied.
Figure 7. Myosin assembly by human p32. a, Electron micro-
graphs of 0.2 mM unphosphorylated myosin alone (1) or mixed
with 0.6 mM human p32 (2). b, Length distribution of myosin fila-
ments formed by human p32. The histogram was obtained by
measurement of 150 filaments. An arrow indicates average
length. c, Quantification of myosin assembly by the sedimenta-
tion assay. Myosin at 1.1 mM was mixed with human p32 and sub-
jected to the centrifugation assay of assembly. Amounts of as-
sembled myosin were plotted against concentration of human
p32. Open and closed circles denote unphosphorylated and phos-
phorylated myosins, respectively.The Journal of Cell Biology, Volume 148, 2000 660
smooth muscle tissues, their homogenates were subjected
to Western blots. The 38k protein was detected in almost
every smooth muscle tissue, including esophagus, stomach,
small intestine, cecum, uterus, aorta, and airway as shown
in Fig. 6 d. It was especially highly expressed in stomach
and digestive tracts. Thus, the 38k protein can be thought
of as a universal component of smooth muscle. It was also
detected in cardiac muscle, but not clearly in skeletal mus-
cle (Fig. 6 d, lanes 10 and 11). It could also be detected in
nonmuscle tissues, such as liver, lung, spleen, and brain
(data not shown), giving good conformity with the pres-
ence of human p32 in a variety of cells (Simon and Geor-
gatos, 1994; Deb and Datta, 1996; Dedia and Muller-Esterl,
1996; Joseph et al., 1996; Tange et al., 1996), but we cannot
exclude the possibility that the reaction was due to con-
tamination by smooth muscle cells from blood vessels.
Colocalization of the 38k Protein with Myosin in 
Cultured Smooth Muscle Cells
To determine whether the 38k protein is associated with
myosin in smooth muscle cells, we examined its localiza-
tion in the cultured smooth muscle cell line, AC01, by indi-
rect immunofluorescence. Double staining (Fig. 8, a and
b), followed by the image analysis (Fig. 8 c), indicates that
the localization of the 38k protein coincides with myosin.
Together with the same staining as shown in Fig. 8, a and
b, the analysis indicates that the 38k protein is associated
with myosin in the whole cells. In the case of the double
staining of the 38k protein (Fig. 8 d) and mitochondria
(Fig. 8 e, see below), the overlapping staining is limited to
the central part of the cell (Fig. 8 f).
To examine whether the 38k protein is localized in the
contractile apparatus composed of myosin and/or actin, we
performed further double staining with antibodies against
components of the contractile apparatus other than myo-
sin. At least two types of actin isoforms are detected in
AC01 cells by Western blotting, a- and b-actin (data not
shown). Localization of the 38k protein in the cells is close
to that of a-actin (Fig. 9, c and d), but does not necessarily
match that of b-actin (Fig. 9, e and f). The localization of
the 38k protein overlaps that of desmin, a major compo-
nent of dense bodies (Fig. 9, g and h).
Human p32 has been found to localize in nuclei (Krai-
ner et al., 1991; Mayeda et al., 1992; Honore et al., 1993;
Luo et al., 1994; Simon and Georgatos, 1994; Nikolankaki
et al., 1996; Tange et al., 1996), mitochondria (Muta et al.,
1997, Jiang et al., 1999), the vesicular fraction (Dedia and
Muller-Esterl, 1996), and at the cell surface (Ghebrehiwet
et al., 1994; Deb and Datta, 1996; Joseph et al., 1996; Lim
et al., 1996). However, in our hands, with cultured smooth
muscle cell, such localization, except in mitochondria,
could not be confirmed clearly (Fig. 8, d–f).
Discussion
In this report, we identified and characterized a novel my-
osin-binding protein of smooth muscle, a protein of 38 kD
that assembles myosin into filaments. The myosin-assem-
bling activity is similar to the activity reported for telokin
(Shirinsky et al., 1993). Telokin binds at the NH2-terminal
end of subfragment-2 of unphosphorylated myosin to
change myosin from the 10S form to the 6S form (Masato
et al., 1997; Silver et al., 1997). Thus, unphosphorylated
myosin can be assembled into filaments. However, the
Figure 8. Localization of the
38k protein in the cultured
smooth muscle cell line
AC01. a–c, Staining pattern
with anti–38k protein (a) and
that with anti-MHC (b) anti-
bodies. To amplify colocal-
ized region of the 38k protein
and MHC, images of a and b
were multiplied in c, i.e., c 5
a  3 b. d–f, The cell was
stained with MitoTracker
Red CMXRos to visualize
position of mitochondria.
Staining pattern with anti-
38k protein (d) and that with
MitoTracker Red CMXRos
(e). To demonstrate colocal-
ized region of the 38k protein
with mitochondria, images of
d and e were multiplied in f,
i.e., f 5 d 3 e. Magnification
is the same in all pictures.
Bar, 30 mm.Okagaki et al. A Myosin-assembling Protein from Smooth Muscle 661
binding site for the 38k protein in the myosin molecule is
different from that of telokin (Figs. 4 and 5).
It must be noted that telokin binds to only unphosphor-
ylated myosin (Shirinsky et al., 1993). Therefore, it is ex-
pected in vitro that telokin may dissociate from myosin fil-
aments to the cytosol when smooth muscle myosin is
phosphorylated upon excitation of smooth muscle cells.
However, because the 38k protein binds to both phos-
phorylated and unphosphorylated myosin, the 38k protein
is thought to remain as a component of myosin filaments,
whether or not smooth muscle cells are excited. The other
distinction is that expression of telokin is limited to only a
few types of smooth muscles (Gallagher and Herring,
1991; Herring and Smith, 1996), but the 38k protein is ex-
pressed in various types of smooth muscle cells, as shown
in Fig. 6 d.
We compared the amino acid sequence of the 38k pro-
tein to other myosin-binding proteins. The similarity of the
amino acid sequence of the 38k protein to telokin (Gal-
lagher and Herring, 1991; Yoshikai and Ikebe, 1992) is un-
expectedly low, ,5%. The 38k protein also showed little
sequence homology with myosin-binding proteins of stri-
ated muscle, such as C-protein (Furst et al., 1992; Okagaki
et al., 1993; Weber et al., 1993), H-protein (Vaughan et al.,
1993), M-protein (Noguchi et al., 1992), and titin (Labeit
et al., 1990), or other components of smooth muscle that
interact with myosin, such as the 130 kD subunit of myosin
phosphatase (Shimizu et al., 1994) and MLCK (Olson et al.,
1990). Thus, the primary structure of the 38k protein is
unique amongst myosin-binding proteins, suggesting that
its myosin-binding, and hence myosin-bundling, activities
are by a novel mode.
Recent analysis of the crystal structure of human p32
showed that it consists of seven consecutive antiparallel
b-sheets flanked by one NH2-terminal and two COOH-
terminal a helices, and that the a helix at the NH2 termi-
Figure 9. Colocalization of
the 38k protein with compo-
nents of contractile apparatus
in the cultured smooth mus-
cle cell line, AC01. a–h, Dou-
ble staining of AC01 cell with
anti-38k protein antibody, as
detected by FITC-labeled
second antibody and with
various antibodies as de-
tected by rhodamine-labeled
second antibody. Staining
pattern with anti-38k protein
antibody (a, c, e, and g) and
with antibodies against MHC
(b), a-actin (d), b-actin (f), or
desmin (h). Magnification is
the same in all pictures. Bar,
30 mm.The Journal of Cell Biology, Volume 148, 2000 662
nus has extensive contact with the COOH terminus (Jiang
et al., 1999). We expect that the myosin-binding site of the
38k protein is at the contact, because deletion of either
NH2-terminal or COOH-terminal residues (Table I) leads
to the loss of myosin-binding activity of the 38k protein.
We quantified the intracellular concentration of the 38k
protein with an antibody as described in Materials and
Methods. Its concentration in gizzard was 6.4 6 0.5 mM,
SD (n 5 3). Since the concentration of myosin is reported
as 46 mM (Yamazaki et al., 1987), the molar ratio of myo-
sin to the 38k protein is z1 to 0.14. Cellular myosin in the
relaxed state is mostly unphosphorylated (for review, see
Somlyo and Somlyo, 1994). From the kinetic profile shown
in Fig. 3 d, the assembly of 1.1 mM unphosphorylated myo-
sin was maximal in the presence of z3 mM of the 38k pro-
tein, indicating that 2.7-fold molar excess of the protein
over myosin was required for full assembly. Therefore, the
cytoplasmic concentration of the 38k protein is too low to
explain  myosin assembly in vivo. The Prosite database
predicts that the 38k protein has residues that can be phos-
phorylated with protein kinase C at Thr130 and with casein
kinase-2 at Thr2, Thr176, Ser185, and Thr86. It is possible that
the myosin-assembling activity may be enhanced upon
phosphorylation of the 38k protein. Another explanation
is that, like thick filaments of skeletal muscle, a few myo-
sin-binding proteins, including telokin (Shirinsky et al.,
1993) and the 38k protein, are working at the same time to
assemble myosin into thick filaments of smooth muscle.
As explained in relation to Fig. 9, the 38k protein has
been reported to be present in a variety of cellular or-
ganelles, including mitochondria, nuclei, vesicles, and cell
surfaces. The present study describes additional localiza-
tion of cytoskeleton. We realized that the variety may be
attributable to that of the cells/organs used for the respec-
tive experiments and speculated that all of them may not
function at once. Rather, they might change according to
the cellular states, e.g., differentiation. The first step in
testing our speculation, we stained smooth muscle cell
(AC01) under two distinct types, i.e., differentiated and
dedifferentiated, using an antibody against the 38k protein
in a similar way described for Figs. 8 and 9. Our unpub-
lished data shows that the antibody densely stained the nu-
cleoli of the dedifferentiated type. However, in the differ-
entiated type, as shown in Figs. 8 and 9, the staining of
nucleoli was obscured with the increase in the cytoskeletal
staining. The results are compatible with our speculation,
but require additional experiments to demonstrate it.
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